← 홈

Antibody · 아토피·피부염

30개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 30개
AntibodyAHOTFDACuratedFDABiologicSanofiApproved

dupilumab (Dupixent)

Atopic dermatitis, asthma, CRSwNP, EoE · IL-4Rα

#IL-4R#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 0.45%임상시험 216상태 APPROVED
AntibodySHOTFDACuratedFDABiologicEli LillyApproved

lebrikizumab (Ebglyss, Lilly)

Atopic dermatitis · IL-13

#IL-13#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 75%임상시험 75상태 APPROVED
AntibodyCSanofiPhase 3

REGN668 (Dupilumab SAR231893, Dupilumab SAR231893 (REGN668))

Prurigo Nodularis · Dermatitis Atopic

#DermatitisAtopic#Antibody#Phase3#인기#항체+5
효능 ORR 0.45%임상시험 70상태 ACTIVE
AntibodyUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#인기#항체+5
효능 ORR 5%임상시험 59상태 RECRUITING
AntibodySanofiApproved

Dupilumab SAR231893 (Dupilumab SAR231893)

Chronic Obstructive Pulmonary Disease · Dermatitis Atopic

#DermatitisAtopic#Antibody#Approved#인기#항체+5
효능 ORR 0.44%임상시험 57상태 ACTIVE
AntibodyJanssenApproved

Guselkumab (Guselkumab)

Psoriasis; Atopic Dermatitis · Skin Inflammation

#SkinInflammation#Antibody#Approved#인기#항체+5
임상시험 55상태 RECRUITING
AntibodyEli Lilly and CompanyApproved

Ixekizumab (Ixekizumab)

Psoriasis; Atopic Dermatitis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Approved#인기#항체+5
임상시험 53상태 RECRUITING
AntibodyUCB Biopharma SRLApproved

Bimekizumab (Bimekizumab)

Psoriasis; Atopic Dermatitis · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Approved#항체#면역항체+4
임상시험 46상태 RECRUITING
AntibodyLEO PharmaApproved

Tralokinumab (Tralokinumab)

Psoriasis; Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+4
효능 ORR 46.962%임상시험 43상태 RECRUITING
AntibodyAlmirall, S.A.Approved

Tildrakizumab (Tildrakizumab)

Psoriasis; Atopic Dermatitis · Psoriasis

#Psoriasis#Antibody#Approved#항체#면역항체+3
효능 ORR 85.07%임상시험 41상태 RECRUITING
AntibodystaleGalderma R&DApproved

Nemolizumab (Nemolizumab)

Psoriasis; Atopic Dermatitis · Psoriasis

#Psoriasis#Antibody#Approved#항체#면역항체+3
임상시험 25상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab Prefilled Syringe (Dupilumab Prefilled Syringe)

Netherton Syndrome · Netherton Syndrome

#NethertonSyndrome#Antibody#Approved#항체#면역항체+2
임상시험 15상태 RECRUITING
AntibodystaleSanofiPreclinical

Dupilumab - Standard Dose (Dupilumab - Standard Dose)

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP); Smell Loss · Atopic Dermatitis

#AtopicDermatitis#Antibody#Preclinical#항체#면역항체+4
임상시험 10상태 RECRUITING
AntibodystaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiPhase 1

dupilumab (DUPIXENT®, DUPIXENT® (dupilumab))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiPhase 2

blinded (Dupilumab, Dupilumab (blinded))

Eosinophilic Gastritis; Eosinophilic Gastroenteritis · Eosinophilic Gastritis

#EosinophilicGastritis#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSanofiApproved

Dupilumab - Discontinuation (Dupilumab - Discontinuation)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab - Dose Reduction (Dupilumab - Dose Reduction)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab Only Product (Dupilumab Only Product)

Atopic Dermatitis; AD · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 1

Dupilumab coformulated with berahyaluronidase alfa (Dupilumab coformulated with berahyaluronidase alfa)

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING

1 / 2 페이지

← 이전다음 →